Xu Zhenye, prominent Chinese Physician in Shanghai, Chief Physician of the Department of Oncology in Longhua Hospital (affiliated to Shanghai University of Traditional Chinese Medicine), a mentor to Ph.D students. Prof. Xu was once the Associate Dean of Longhua Hospital (affiliated to Shanghai University of Traditional Chinese Medicine), Dean of the Pudong Branch, Director of the Oncology Research Department in Shanghai University of Traditional Chinese Medicine.

He is the current Deputy Director of Integrative Oncology Committee of China, Director of the oncology section of the World Federation of Chinese Medical Societies, Executive Member of the Chinese Geriatric Oncology Society, Member of Shanghai Cancer Society, Deputy Director of Shanghai Traditional Chinese Medicine Cancer Clinical Center, Shanghai University of Traditional Chinese Medicine Cancer Institute Consultant, Pudong New Area CPPCC ESCH Distinguished Member and more. Prof. Xu has hosted, guided and participated in China’s 6.5 and 7.5 key issues, National Natural Science Foundation, over 40 major topics at ministerial, city and bureau levels. He has also received over 11 prizes for technological achievements at ministerial and city level, won 2 national invention patents, published more than 130 academic journals, of which includes 9 articles in the Science Citation Index, edited 11 articles of monographs, nurtured more than 30 PhD and Masters students. He has also given lectures in countries such as Germany, South Korea, Japan, Portugal, United States of America, United Kingdom, Australia, Thailand, Hong Kong, Taiwan and spoken in the International Cancer Forum.

For the past 36 years, Professor Xu Zhenye has committed himself to the clinical practice and research in both Western and Chinese Medicine, thus accumulating a wealth of clinical experience and numerous academic attainments. He advocated the TCM yi qi yang jing detoxification method, the TCM treatment of non-small cell lung cancer in stages, developed fei yan ning granules, his research study involved 400 cases of late-stage lung cancer, the median survival period and long-term survival rate is leading nationwide and attained advanced level internationally. There is in-depth and multi-target research at the cellular, molecular level as well as the immune mechanism.

Professor Xu favored the use of TCM yi qi yang jing bu shen shen sui fa to prevent the bone marrow suppression during chemotherapy, developed shuang huang shen bai. His research study involved more than 500 cases of clinical cases, substantiating that the granules have the function of preventing mid to severe bone marrow suppression during chemotherapy, a first in the TCM Oncology arena. Through systematic laboratory research, it was discovered that shuang huang shen bai granules not only had a stimulating effect on the bone marrow for blood production, but it can also suppress the growth of cancerous cells. He won the 25th Shanghai Outstanding Invention Technological Innovation Award in 2013, with the granules successfully transferred to enterprises for production and distribution.

Professor Xu specialises in using integrative medicine, mainly through the use of Chinese Medicine, for the treatment and management of most types of Cancer and the complications arising from cancer treatment.